Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Filgrastim × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Myelodysplastic Syndromes 15 Hodgkin Disease 11 Lymphoma, Non-Hodgkin 10 Lymphoma 8 Leukemia, Biphenotypic, Acute 8 Leukemia 8 Lymphoma, Large B-Cell, Diffuse 7 Burkitt Lymphoma 7 Breast Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hematologic Neoplasms 5 Neoplasms 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Chronic 4 Anemia, Refractory, with Excess of Blasts 4 Triple Negative Breast Neoplasms 3 Rhabdomyosarcoma 3 Medulloblastoma 3 Lymphoma, Follicular 3 Recurrence 2 Neuroblastoma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, AIDS-Related 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myelomonocytic, Acute 2

Interventions

Cisplatin 7 Etoposide 6 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Bleomycin 3 Automobiles 3 pralsetinib 2 pembrolizumab 2 etoposide phosphate 2 Sirolimus 2 Paclitaxel 2 Mesna 2 Drug Therapy 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 tozuleristide 1 sodium thiosulfate 1 repotrectinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Vorinostat 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02582697 2025-06-15

P3BEP

University of Sydney

Phase 3 Recruiting

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡